Adial Pharmaceuticals, Inc.ADIL

$2.60-0.15 (-5.45%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$4M

Micro-cap

-87%

2018 — today

10-Year Price

-100%

2018 — today

52-Week Range

$1.36$15.75

Current $2.60· 9%

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.

Valuation in context

P/E ratio

-0.3

N/A

Not meaningful — company is unprofitable

P/B ratio

1.0

Historically cheap

Historically cheap relative to the last 10 years

FCF Yield

-183.0%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when ADIL is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.